INTERNATIONAL PATENT: INXMED (NANJING) CO., LTD., 应世生物科技（南京）有限公司 FILES APPLICATION FOR "ANTIBODY TARGETING INTEGRIN Α3Β1 OR ANTIGEN-BINDING FRAGMENT THEREOF AND USE THEREOF"

GENEVA, Jan. 12 -- INXMED (NANJING) CO., LTD. (3rd Floor, Block D-2, 73 Tanmi Road, Jiangbei New DistrictNanjing, Jiangsu 210000), 应世生物科技（南京）有限公司 (中国江苏省南京市江北新区探秘路73号树屋十六栋D-2栋3层) filed a patent application (PCT/CN2025/105614) for "ANTIBODY TARGETING INTEGRIN Alpha3Beta1 OR ANTIGEN-BINDING FRAGMENT THEREOF, AND USE THEREOF" on Jun 30, 2025. With publication no. WO/2026/007893, the details related to the patent application was published on Jan 08, 2026.

Notably, the patent application was...